Ta Hsung Tung

Array ( [id] => 12387774 [patent_doc_number] => 09963497 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-08 [patent_title] => Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28 [patent_app_type] => utility [patent_app_number] => 15/035571 [patent_app_country] => US [patent_app_date] => 2014-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 62 [patent_no_of_words] => 18064 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 452 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10265970 [patent_doc_number] => 20150150968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'USE OF CD28-SPECIFIC MONOCLONAL ANTIBODIES FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR TREATING VIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/554590 [patent_app_country] => US [patent_app_date] => 2014-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8653 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12192788 [patent_doc_number] => 09896507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-20 [patent_title] => 'BTLA antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/550429 [patent_app_country] => US [patent_app_date] => 2014-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 12551 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14550429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032687 [patent_doc_number] => 09073994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Immunopotentiative composition' [patent_app_type] => utility [patent_app_number] => 14/550585 [patent_app_country] => US [patent_app_date] => 2014-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 32 [patent_no_of_words] => 13931 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14550585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10044394 [patent_doc_number] => 09084776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Methods for treating cancer using anti-PD-1 antibodies' [patent_app_type] => utility [patent_app_number] => 14/547026 [patent_app_country] => US [patent_app_date] => 2014-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 93 [patent_no_of_words] => 50074 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11888037 [patent_doc_number] => 09758589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Methods for enhancing anti-tumor antibody therapy' [patent_app_type] => utility [patent_app_number] => 14/542233 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 53 [patent_no_of_words] => 11118 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14542233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14551295 [patent_doc_number] => 10344090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-09 [patent_title] => PD-1 antibody, antigen-binding fragment thereof, and medical application thereof [patent_app_type] => utility [patent_app_number] => 15/103758 [patent_app_country] => US [patent_app_date] => 2014-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8951 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10254997 [patent_doc_number] => 20150139994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREVENTING ALLOGENEIC IMMUNE REJECTION' [patent_app_type] => utility [patent_app_number] => 14/539271 [patent_app_country] => US [patent_app_date] => 2014-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12274 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14539271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10790095 [patent_doc_number] => 20160136251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'CD4 T Cell Vaccine and Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/535940 [patent_app_country] => US [patent_app_date] => 2014-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8647 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14535940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10346210 [patent_doc_number] => 20150231215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'VISTA Antagonist and Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/534793 [patent_app_country] => US [patent_app_date] => 2014-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18062 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14534793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10240960 [patent_doc_number] => 20150125955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'PD-1 MODULATION AND USES THEREOF FOR MODULATING HIV REPLICATION' [patent_app_type] => utility [patent_app_number] => 14/531403 [patent_app_country] => US [patent_app_date] => 2014-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14638 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14531403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10381951 [patent_doc_number] => 20150266958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/528566 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 157409 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14528566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11480476 [patent_doc_number] => 09587007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'CTLA4 proteins and their uses' [patent_app_type] => utility [patent_app_number] => 14/524946 [patent_app_country] => US [patent_app_date] => 2014-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 39 [patent_no_of_words] => 30641 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14524946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10219416 [patent_doc_number] => 20150104409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES TO CTLA-4' [patent_app_type] => utility [patent_app_number] => 14/518990 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 32462 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9936887 [patent_doc_number] => 08986693 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-03-24 [patent_title] => 'Use of TNFα inhibitor for treatment of psoriasis' [patent_app_type] => utility [patent_app_number] => 14/510821 [patent_app_country] => US [patent_app_date] => 2014-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 23774 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14510821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025166 [patent_doc_number] => 20160222121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'METHODS FOR TREATING HEMATOLOGIC CANCERS' [patent_app_type] => utility [patent_app_number] => 15/024396 [patent_app_country] => US [patent_app_date] => 2014-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 46302 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10491257 [patent_doc_number] => 20150376278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'USE OF A CD28 BINDING PHARMACEUTICAL SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION WITH DOSE-DEPENDENT EFFECT' [patent_app_type] => utility [patent_app_number] => 14/492675 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7615 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14492675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13127521 [patent_doc_number] => 10081681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors [patent_app_type] => utility [patent_app_number] => 15/021102 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23810 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025165 [patent_doc_number] => 20160222120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Anti-B7-H1 Antibodies for Treating Tumors' [patent_app_type] => utility [patent_app_number] => 15/021161 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15053 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11025158 [patent_doc_number] => 20160222113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-04 [patent_title] => 'Antibodies Against PD-1 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/021088 [patent_app_country] => US [patent_app_date] => 2014-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16025 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021088 [rel_patent_id] =>[rel_patent_doc_number] =>)